Reagents for extracellular DNA isolation from 1ml plasma

Auto-translated from lv

Original title: Reaģenti ārpusšūnu DNS izdalīšanai no 1ml plazmas

SIA „Rīgas Austrumu klīniskā universitātes slimnīca”

Published: Oct 7, 2026

Updated: Oct 7, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals and Laboratory. Located in Latvia, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: lv

This tender, originating from Latvia and sourced via TED, concerns the procurement of reagents for the isolation of extracellular DNA from plasma. The contracting authority is seeking specialized reagents and associated consumables crucial for precision oncology applications. This type of procurement typically involves sourcing high-quality biochemicals and kits designed for molecular biology workflows. Requirements often include strict specifications regarding purity, performance, compatibility with specific sample types (in this case, 1ml plasma), and lot-to-lot consistency. Bidders are expected to provide detailed product information, including technical data sheets, certifications, and evidence of prior successful use in similar diagnostic or research settings. The tender may also specify delivery timelines, storage conditions, and ongoing technical support. The focus on precision oncology suggests a need for reagents that enable accurate and reliable detection or analysis of genetic material relevant to cancer diagnosis, prognosis, or treatment monitoring. Suppliers should be prepared to demonstrate their capacity to meet these demanding requirements and ensure the integrity of the supply chain for sensitive biological materials.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on October 7, 2026. Last refreshed today. Original language: lv. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About SIA „Rīgas Austrumu klīniskā universitātes slimnīca”

SIA „Rīgas Austrumu klīniskā universitātes slimnīca” has issued 147 procurement notices on BidsFactory, including 6 currently open and 70 awarded contracts. Activity concentrates in Health & Medical, Architecture & Engineering Services, and General Supplies & Services. All notices are published for Latvia. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: October 7, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Latvia. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by SIA „Rīgas Austrumu klīniskā universitātes slimnīca” in Latvia. The authority is responsible for evaluating bids, awarding the contract, and managing performance.